Phase 3 Pancreatitis Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Recruiting
Phase 3
Evaluating the Efficacy of RELiZORB in Managing Exocrine Pancreatic Insufficiency in Tube-fed Pancreatitis Patients
PancreatitisExocrine Pancreatic Insufficiency (EPI)
Massachusetts General Hospital60 enrolled1 locationNCT06691893
Recruiting
Phase 3
Pancreatic Enzyme Replacement in Acute Necrotizing Pancreatitis
Pancreatic exocrine insufficiencyAcute Necrotizing Pancreatitis
Asian Institute of Gastroenterology, India140 enrolled4 locationsNCT07441824
Recruiting
Phase 3
Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP Pancreatitis
Post-ERCP Acute Pancreatitis
Johns Hopkins University4,874 enrolled5 locationsNCT05252754
Recruiting
Phase 3
Ursodeoxycolic Acid for the Prevention of Relapsing Complications After Gallstone Acute Pancreatitis
Acute Pancreatitis Due to Gallstones
Hospital General Universitario de Alicante332 enrolled18 locationsNCT04924868
Recruiting
Phase 3
Comparative Effectiveness Between Indomethacin and Pancreatic Stenting in the Prevention of Post ERCP Pancreatitis
Post-ERCP pancreatitis
Chinese University of Hong Kong1,734 enrolled7 locationsNCT03713879